DESFERAL 500MG

Google image searchProduct monograph

Active ingredient

deferoxamine mesylate, 500 MG/VIAL

DIN: 01981242

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAMUSCULAR, INTRAPERITONEAL, INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 10-MAY-1999

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AC — Iron chelating agents (ATC, ATC/DDD)
• V03AC01 — DEFEROXAMINE (ATC/DDD)

Reference brand drug: Desferal

Pharmaceutical standard: MFR

External Links for Desferal 500Mg

Search on Google

• Desferal 500Mg side effects
• Desferal 500Mg dosage
• deferoxamine mesylate side effects
• deferoxamine mesylate dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find desferal 500mg photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.